| abstract |
The invention relates to novel substituted pyrrolidinones of general formula (I), in which A, X, B and R<SUP>1</SUP> to R<SUP>9</SUP> are defined as in Claim 1, to their tautomers, enantiomers, diastereomers, mixtures and their salts, particularly their physiologically compatible salts with inorganic or organic acids or bases, which have valuable properties, in particular, an antithrombotic effect and a factor xa-inhibitory effect. |